The ongoing outbreak of coronavirus disease 2019 (COVID-19) started in December of 2019. It has surpassed the death toll of the SARS outbreak of 2003.
In 2018, a lot happened in global pharmaceuticals industry. For example, the approval of second CAR T-cell therapy tisagenlecleucel (Kymriah) signified the dramatic progress in the field. While the industry witnessed uncertainties due to the U.S. presidential elections and weak economic growth in 2017, steady growth has returned.
BCC Research’s just published report Opioid Drugs: Global Markets to 2023 provides a comprehensive overview of the opioid market as well as the market for abuse prevention technologies. This edited excerpt provides an overview of a few of these emerging technologies.